Skip to Content

America Great Health AAGH

Morningstar Rating
$0.00 0.00 (10.34%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AAGH is trading at a 215% premium.
Price
$0.00
Fair Value
$4.29
Uncertainty
Extreme
1-Star Price
$2.75
5-Star Price
$7.39
Economic Moat
Htcv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AAGH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.03
Bid/Ask
$0.00 / $0.00
Market Cap
$55.09 Mil
Volume/Avg
19,800 / 9.0 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
200.00
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
7

Comparables

Valuation

Metric
AAGH
PTGX
RXDX
Price/Earnings (Normalized)
13.68
Price/Book Value
3.4913.67
Price/Sales
200.006.362,138.36
Price/Cash Flow
10.46
Price/Earnings
AAGH
PTGX
RXDX

Financial Strength

Metric
AAGH
PTGX
RXDX
Quick Ratio
0.0415.6136.90
Current Ratio
0.0815.7237.56
Interest Coverage
−1.46
Quick Ratio
AAGH
PTGX
RXDX

Profitability

Metric
AAGH
PTGX
RXDX
Return on Assets (Normalized)
−270.15%51.28%−27.00%
Return on Equity (Normalized)
56.32%−30.83%
Return on Invested Capital (Normalized)
51.24%−31.90%
Return on Assets
AAGH
PTGX
RXDX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
ZrfpjcnyNrmppl$124.1 Bil
Regeneron Pharmaceuticals Inc
REGN
LgknqfrbYbndy$114.2 Bil
Moderna Inc
MRNA
YgjgdrhrFdhl$53.7 Bil
argenx SE ADR
ARGX
JbbcwlxkTgb$23.0 Bil
BioNTech SE ADR
BNTX
ZxwzgymyYrsb$22.2 Bil
Alnylam Pharmaceuticals Inc
ALNY
HpbjfrntjGtlhbr$20.3 Bil
Biomarin Pharmaceutical Inc
BMRN
BmdvmckNhdgwjn$15.9 Bil
United Therapeutics Corp
UTHR
HmhvcffkGlqw$12.8 Bil
Incyte Corp
INCY
PjrkpmvfDvjcc$12.2 Bil
Royalty Pharma PLC Class A
RPRX
HczxmphjNwnql$12.2 Bil

Sponsor Center